Iii Capital Management Pacira Bio Sciences, Inc. Transaction History

Iii Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $321,452 - $509,678	-6,243 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$60.03 - $76.49 $374,767 - $477,527	6,243 New	6,243 $476,000
Q4 2021 Feb 15, 2022	SELL	$47.97 - $62.21 $671,580 - $870,940	-14,000 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$54.64 - $61.3 $764,960 - $858,200	14,000 New	14,000 $784,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Iii Capital Management, based on Form 13F filings with the SEC.

Stay updated on Iii Capital Management with notifications on news.